Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Imane Ajana"'
Autor:
Imane Ajana, Driss Nehari, Driss Khalil, Abdelmalek Taoutioui, Hicham Agueny, Abdelkader Makhoute
Publikováno v:
Atoms, Vol 9, Iss 3, p 67 (2021)
We report on a joined experimental and theoretical study of differential cross-sections resulting from inelastic scattering of a monoenergetic electron by helium atoms in the presence of an intense carbon dioxide laser. In particular, we measured the
Externí odkaz:
https://doaj.org/article/68c8e65cd8c84371adf6991125930164
Publikováno v:
Atoms, Vol 7, Iss 2, p 40 (2019)
In this review, we present a comprehensive survey of laser-assisted (e, 2e) reactions. The influence of a laser field on the dynamics of (e, 2e) collisions in atomic hydrogen is analyzed in the symmetric and asymmetric coplanar geometries. Particular
Externí odkaz:
https://doaj.org/article/8f31e463049d4eb4a123073a96ad7e07
Publikováno v:
Drug Development and Industrial Pharmacy
Drug Development and Industrial Pharmacy, Taylor & Francis, 2010, 36 (4), pp.421-7. ⟨10.3109/03639040903225083⟩
Drug Development and Industrial Pharmacy, Taylor & Francis, 2010, 36 (4), pp.421-7. ⟨10.3109/03639040903225083⟩
International audience; BACKGROUND: Mitotane (o,p'-DDD) is considered to be the drug of choice in the treatment of nonresectable and metastasized adrenocortical carcinoma. However, mitotane has poor solubility in the gastrointestinal tract and very l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165bd26d9bc4583a7f0780a55edd8a7e
https://doi.org/10.3109/03639040903225083
https://doi.org/10.3109/03639040903225083
Publikováno v:
European journal of drug metabolism and pharmacokinetics
European journal of drug metabolism and pharmacokinetics, Springer, 2010, 35 (1-2), pp.59-65. ⟨10.1007/s13318-010-0009-6⟩
European journal of drug metabolism and pharmacokinetics, Springer, 2010, 35 (1-2), pp.59-65. ⟨10.1007/s13318-010-0009-6⟩
International audience; Recent investigations have shown that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c3aedc1f2bb352694a7d4f85e2c292
https://pubmed.ncbi.nlm.nih.gov/21495268
https://pubmed.ncbi.nlm.nih.gov/21495268
Publikováno v:
J Pharm Pharmacol
J Pharm Pharmacol, 2009, 61 (10), pp.1295-301. ⟨10.1211/jpp/61.10.0004⟩
Scopus-Elsevier
J Pharm Pharmacol, 2009, 61 (10), pp.1295-301. ⟨10.1211/jpp/61.10.0004⟩
Scopus-Elsevier
Objectives The organoarsenical arsthinol was used in the 1950s in the treatment of amoebiasis and yaws and was considered as ‘highly tolerated’. The aim of this work was to study its anti-leukaemic activity and to develop nanosuspensions of the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c261b1f6456cf7cca8bf5715bc51aef0
https://hal.archives-ouvertes.fr/hal-00689719/document
https://hal.archives-ouvertes.fr/hal-00689719/document
Publikováno v:
Journal of Pharmacy & Pharmacology; Oct2009, Vol. 61 Issue 10, p1295-1301, 7p